
Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …

The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …

Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …

The pharma industry must be given greater monetary help to persuade it to develop drugs which are specifically for children, …

A method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity …
An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …
The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …
The Institute of Clinical Research (ICR) is to hold its next annual spring conference and exhibition on 19-20 April at …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

